銵?鋆蔭?詨
ABOUT US PIPELINE
LBS-008
LBS-009
LBS-007
LBS-002
MEDIA & PUBLICATION
NEWS
PUBLICATION
INVESTORS
Events & Presentation
Investor Conference
Financial Information
Corporate Governance
CONTACT US
MEDIA & PUBLICATION
HOMEMEDIA & PUBLICATIONNEWS
NEWS
PUBLICATION
NEWS
Lin BioScience Receives US FDA Orphan Drug Status for LBS-008 for the Treatment of Stargardt Disease
Oct 30 , 2017
“No-Strings-Attached”, JLABS’s crown jewel
Oct 02 , 2017
Lin BioScience Announces Acceptance Into World-Class Biotech Innovation Labs to Accelerate Product Development
Jun 15 , 2017
Lin BioScience Licenses Novel Therapeutic Program for Brain Cancer from the University of Sydney
Mar 21 , 2017
Lin BioScience Licenses a Novel Anti-Cancer Therapy for Hematological Malignancies and Solid Tumors from Columbia University and Memorial Sloan Kettering Cancer Center
Mar 03 , 2017